Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 10—October 2008
Perspective

Rise and Persistence of Global M1T1 Clone of Streptococcus pyogenes

Ramy K. AzizComments to Author  and Malak Kotb
Author affiliations: Cairo University, Cairo, Egypt (R.K. Aziz); VA Medical Center, Memphis, Tennessee, USA (R.K. Aziz, M. Kotb)University of Tennessee Health Science Center, Memphis (M. Kotb); University of Cincinnati, Cincinnati, Ohio, USA (M. Kotb);

Main Article

Figure 1

Suggested model for toxin mobilization between phages, reprinted from Aziz et al. (19). Recombination hot spots on both sides of the toxin genes are shown: one is prx (paratox), and the other may be lys (lysin), hol (holin), or hylP (phage hyaluronidase).

Figure 1. Suggested model for toxin mobilization between phages, reprinted from Aziz et al. (19). Recombination hot spots on both sides of the toxin genes are shown: one is prx (paratox), and the other may be lys (lysin), hol (holin), or hylP (phage hyaluronidase).

Main Article

References
  1. Facklam  RF, Martin  DR, Lovgren  M, Johnson  DR, Efstratiou  A, Thompson  TA, Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis. 2002;34:28–38. DOIPubMedGoogle Scholar
  2. Kotb  M, Norrby-Teglund  A, McGeer  A, El-Sherbini  H, Dorak  MT, Khurshid  A, An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med. 2002;8:1398–404. DOIPubMedGoogle Scholar
  3. Chatellier  S, Ihendyane  N, Kansal  RG, Khambaty  F, Basma  H, Norrby-Teglund  A, Genetic relatedness and superantigen expression in group A Streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun. 2000;68:3523–34. DOIPubMedGoogle Scholar
  4. Davies  HD, McGeer  A, Schwartz  B, Green  K, Cann  D, Simor  AE, Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med. 1996;335:547–54. DOIPubMedGoogle Scholar
  5. Katz  AR, Morens  DM. Severe streptococcal infections in historical perspective. Clin Infect Dis. 1992;14:298–307.PubMedGoogle Scholar
  6. Hoge  CW, Schwartz  B, Talkington  DF, Breiman  RF, MacNeill  EM, Englender  SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA. 1993;269:384–9. DOIPubMedGoogle Scholar
  7. Low  DE, Schwartz  B, McGeer  A. The reemergence of severe group A streptococcal disease: an evolutionary perspective. In: Scheld WM, Armstrong D, Hughes JM, editors. Emerging infections. Washington: ASM Press; 1997. p. 93–123.
  8. Infections WGoSS. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA. 1993;269:390–1. DOIPubMedGoogle Scholar
  9. Kaul  R, McGeer  A, Low  DE, Green  K, Schwartz  B. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med. 1997;103:18–24. DOIPubMedGoogle Scholar
  10. Sharkawy  A, Low  DE, Saginur  R, Gregson  D, Schwartz  B, Jessamine  P, Severe group A streptococcal soft-tissue infections in Ontario: 1992–1996. Clin Infect Dis. 2002;34:454–60. DOIPubMedGoogle Scholar
  11. Johnson  DR, Wotton  JT, Shet  A, Kaplan  EL. A comparison of group A streptococci from invasive and uncomplicated infections: Are virulent clones responsible for serious streptococcal infections? J Infect Dis. 2002;185:1586–95. DOIPubMedGoogle Scholar
  12. Rogers  S, Commons  R, Danchin  MH, Selvaraj  G, Kelpie  L, Curtis  N, Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A Streptococcus infections. J Infect Dis. 2007;195:1625–33. DOIPubMedGoogle Scholar
  13. Ikebe  T, Murai  N, Endo  M, Okuno  R, Murayama  S, Saitoh  K, Changing prevalent T serotypes and emm genotypes of Streptococcus pyogenes isolates from streptococcal toxic shock-like syndrome (TSLS) patients in Japan. Epidemiol Infect. 2003;130:569–72.PubMedGoogle Scholar
  14. Cleary  PP, Kaplan  EL, Handley  JP, Wlazlo  A, Kim  MH, Hauser  AR, Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet. 1992;339:518–21. DOIPubMedGoogle Scholar
  15. Ferretti  JJ, McShan  WM, Ajdic  D, Savic  DJ, Savic  G, Lyon  K, Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci U S A. 2001;98:4658–63. DOIPubMedGoogle Scholar
  16. Beres  SB, Musser  JM. Contribution of exogenous genetic elements to the group A Streptococcus metagenome. PLoS One. 2007;2:e800. DOIPubMedGoogle Scholar
  17. Beres  SB, Sylva  GL, Sturdevant  DE, Granville  CN, Liu  M, Ricklefs  SM, Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci U S A. 2004;101:11833–8. DOIPubMedGoogle Scholar
  18. Cleary  PP, LaPenta  D, Vessela  R, Lam  H, Cue  D. A globally disseminated M1 subclone of group A streptococci differs from other subclones by 70 kilobases of prophage DNA and capacity for high-frequency intracellular invasion. Infect Immun. 1998;66:5592–7.PubMedGoogle Scholar
  19. Aziz  RK, Edwards  RA, Taylor  WW, Low  DE, McGeer  A, Kotb  M. Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J Bacteriol. 2005;187:3311–8. DOIPubMedGoogle Scholar
  20. Aziz  RK, Ismail  SA, Park  HW, Kotb  M. Post-proteomic identification of a novel phage-encoded streptodornase, Sda1, in invasive M1T1 Streptococcus pyogenes. Mol Microbiol. 2004;54:184–97. DOIPubMedGoogle Scholar
  21. Sumby  P, Porcella  SF, Madrigal  AG, Barbian  KD, Virtaneva  K, Ricklefs  SM, Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J Infect Dis. 2005;192:771–82. DOIPubMedGoogle Scholar
  22. Overbeek  R, Begley  T, Butler  RM, Choudhuri  JV, Chuang  HY, Cohoon  M, The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res. 2005;33:5691–702. DOIPubMedGoogle Scholar
  23. Cone  LA, Woodard  DR, Schlievert  PM, Tomory  GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med. 1987;317:146–9.PubMedGoogle Scholar
  24. Schlievert  PM, Bettin  KM, Watson  DW. Production of pyrogenic exotoxin by groups of streptococci: association with group A. J Infect Dis. 1979;140:676–81.PubMedGoogle Scholar
  25. Nelson  K, Schlievert  PM, Selander  RK, Musser  JM. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J Exp Med. 1991;174:1271–4. DOIPubMedGoogle Scholar
  26. Buchanan  JT, Simpson  AJ, Aziz  RK, Liu  GY, Kristian  SA, Kotb  M, DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol. 2006;16:396–400. DOIPubMedGoogle Scholar
  27. Walker  MJ, Hollands  A, Sanderson-Smith  ML, Cole  JN, Kirk  JK, Henningham  A, DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med. 2007;13:981–5. DOIPubMedGoogle Scholar
  28. Basma  H, Norrby-Teglund  A, Guedez  Y, McGeer  A, Low  DE, El-Ahmedy  O, Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun. 1999;67:1871–7.PubMedGoogle Scholar
  29. Norrby-Teglund  A, Kaul  R, Low  DE, McGeer  A, Newton  DW, Andersson  J, Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol. 1996;156:3057–64.PubMedGoogle Scholar
  30. Tillet  WS, Sherry  S, Christensen  LR. Streptococcal desoxyribonuclease: significance in lysis of purulent exudates and production by srains of hemolytic streptococci. Proc Soc Exp Biol Med. 1948;68:184–8.PubMedGoogle Scholar
  31. Sumby  P, Barbian  KD, Gardner  DJ, Whitney  AR, Welty  DM, Long  RD, Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci U S A. 2005;102:1679–84. DOIPubMedGoogle Scholar
  32. Brinkmann  V, Reichard  U, Goosmann  C, Fauler  B, Uhlemann  Y, Weiss  DS, Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532–5. DOIPubMedGoogle Scholar
  33. Sumby  P, Whitney  AR, Graviss  EA, DeLeo  FR, Musser  JM. Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2006;2:e5. DOIPubMedGoogle Scholar
  34. Savic  DJ, McShan  WM, Ferretti  JJ. Autonomous expression of the slo gene of the bicistronic nga-slo operon of Streptococcus pyogenes. Infect Immun. 2002;70:2730–3. DOIPubMedGoogle Scholar
  35. Ghosh  J, Caparon  MG. Specificity of Streptococcus pyogenes NAD(+) glycohydrolase in cytolysin-mediated translocation. Mol Microbiol. 2006;62:1203–14. DOIPubMedGoogle Scholar
  36. Talkington  DF, Schwartz  B, Black  C, Todd  J, Elliott  J, Breiman  R, Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun. 1993;61:3369–74.PubMedGoogle Scholar
  37. Kansal  RG, McGeer  A, Low  DE, Norrby-Teglund  A, Kotb  M. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun. 2000;68:6362–9. DOIPubMedGoogle Scholar
  38. Cole  JN, McArthur  JD, McKay  FC, Sanderson-Smith  ML, Cork  AJ, Ranson  M, Trigger for group A streptococcal M1T1 invasive disease. FASEB J. 2006;20:1745–7. DOIPubMedGoogle Scholar
  39. Aziz  RK, Pabst  MJ, Jeng  A, Kansal  R, Low  DE, Nizet  V, Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol. 2004;51:123–34. DOIPubMedGoogle Scholar
  40. Lyon  WR, Gibson  CM, Caparon  MG. A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes. EMBO J. 1998;17:6263–75. DOIPubMedGoogle Scholar

Main Article

Page created: July 13, 2010
Page updated: July 13, 2010
Page reviewed: July 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external